Pfizer shares rise after Q1 earnings beat estimates and full-year outlook confirmed

Pfizer reported first-quarter earnings that exceeded Wall Street expectations, leading to a slight increase in its stock price during premarket trading. The company also reaffirmed its financial guidance for the full year 2026, signaling confidence in its ongoing performance. This positive earnings report may boost investor confidence and influence Pfizer's stock movement in the near term.